Skip to main content
. 2022 Sep 5;15:963–971. doi: 10.2147/OTT.S374908

Table 1.

Function of JNK in Bladder Cancer

Category JNK Function Corresponding References
Tumorigenesis Phosphorylate AP-1 proteins
Involved in AKT1 binding to JIP1
[32–40]
Cell proliferation Regulate cell death and cell survival through FAS and TNF
Inhibit JNK-enhanced bladder cancer cell apoptosis
Inhibit cell growth via p21WAF1 activation
Activate caspase-9, −8, and −3
Mediate apoptosis by regulating TGF-β1
[2,41–49]
Metastasis Increase miR-200c transcription
Decrease migration by inhibiting SOD2-induced JNK activation
[50–61]
Chemoresistance Increase chemosensitivity through p53 [39,61,75,76]
Autophagy Induce Bcl-2/Beclin-1 complex breakdown
Activate autophagic reaction
Attenuate gemcitabine-induced JNK activation through HMGB1 knockdown
[1,24,61–70]
Metabolism and Immune escape Regulate lipid metabolism through MEX3C
Enhance immune response by suppressing PD-L1
[71–74]

Abbreviations: AP-1, Activator protein 1; AKT, Ak strain transforming; JIP1, JNK-interacting protein 1; FAS, Fas Cell Surface Death Receptor; TNF, Tumor necrosis factor; JNK, c-Jun N-terminal kinases; p21WAF1, cyclin-dependent kinase inhibitor 1; TGF-β1, Transforming growth factor beta 1; SOD, Superoxide dismutase; Bcl-2, B-cell lymphoma 2; HMGB1, High mobility group box 1 protein, also known as high-mobility group protein; MEX3C, Mex-3 RNA Binding Family Member C; PD-L1, Programmed death-ligand 1.